ATE385807T1 - Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug - Google Patents
Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzugInfo
- Publication number
- ATE385807T1 ATE385807T1 AT03760800T AT03760800T ATE385807T1 AT E385807 T1 ATE385807 T1 AT E385807T1 AT 03760800 T AT03760800 T AT 03760800T AT 03760800 T AT03760800 T AT 03760800T AT E385807 T1 ATE385807 T1 AT E385807T1
- Authority
- AT
- Austria
- Prior art keywords
- arginine
- withdrawal
- methods
- pharmaceutical compound
- treating human
- Prior art date
Links
- 239000004475 Arginine Substances 0.000 title abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title abstract 2
- 201000009030 Carcinoma Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 102000004452 Arginase Human genes 0.000 abstract 1
- 108700024123 Arginases Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39075702P | 2002-06-20 | 2002-06-20 | |
| PCT/CN2002/000635 WO2004001048A1 (en) | 2002-06-20 | 2002-09-09 | Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE385807T1 true ATE385807T1 (de) | 2008-03-15 |
Family
ID=30000613
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03760800T ATE385807T1 (de) | 2002-06-20 | 2003-06-20 | Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug |
| AT08001266T ATE461707T1 (de) | 2002-06-20 | 2003-06-20 | Pharmazeutische verbindung und methoden zur behandlungen von menschliche karzinome mittels arginin entzug |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08001266T ATE461707T1 (de) | 2002-06-20 | 2003-06-20 | Pharmazeutische verbindung und methoden zur behandlungen von menschliche karzinome mittels arginin entzug |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US7951366B2 (de) |
| EP (1) | EP1517699B1 (de) |
| JP (2) | JP5307042B2 (de) |
| CN (2) | CN101433714A (de) |
| AT (2) | ATE385807T1 (de) |
| AU (1) | AU2002325782A1 (de) |
| DE (2) | DE60319083T2 (de) |
| HK (1) | HK1053577A2 (de) |
| IL (1) | IL165858A (de) |
| MX (1) | MXPA04012970A (de) |
| NZ (1) | NZ537774A (de) |
| WO (1) | WO2004001048A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1745847A (zh) * | 2004-09-08 | 2006-03-15 | 康达医药科技有限公司 | 用精氨酸酶治疗肝炎的药物组合物和方法 |
| CN101002945B (zh) * | 2006-01-20 | 2012-09-05 | 清华大学 | 一种用于肿瘤治疗的新型复合物 |
| EP1996225A1 (de) * | 2006-03-17 | 2008-12-03 | Bio-Cancer Treatment International Limited | Verfahren und zusammensetzung zum schutz vor strahlung |
| US20080138858A1 (en) * | 2006-12-12 | 2008-06-12 | Bio-Cancer Treatment International Ltd. | Expression System for Recombinant Human Arginase I |
| US8815232B2 (en) * | 2008-08-26 | 2014-08-26 | Kyon Biotech Ag | Compositions and methods for treating cancer |
| PT3778885T (pt) | 2008-10-31 | 2023-05-31 | Aerase Inc | Composições de arginases humanas modificadas e métodos para o tratamento do cancro |
| EP2411040B1 (de) | 2009-03-26 | 2015-09-23 | The Hong Kong Polytechnic University | Ortsgerichtete pegylierung von arginasen und ihre verwendung als antikrebs- und antivirales mittel |
| JP2012531893A (ja) * | 2009-06-29 | 2012-12-13 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | アルギナーゼ製剤および方法 |
| CN103184208B (zh) * | 2011-12-27 | 2015-09-16 | 拜奥生物科技（上海）有限公司 | 人精氨酸酶和定点聚乙二醇化人精氨酸酶及其应用 |
| WO2015165374A1 (en) | 2014-04-29 | 2015-11-05 | Bio-Cancer Treatment International Limited | Methods and compositions for modulating the immune system with arginase i |
| JP2016117702A (ja) * | 2014-12-22 | 2016-06-30 | 武輝 山田 | ガン細胞の死滅法 |
| CN105062941B (zh) * | 2015-08-25 | 2019-03-05 | 江南大学 | 一种利用重组枯草芽孢杆菌全细胞转化生产l-鸟氨酸的方法 |
| WO2017050240A1 (en) * | 2015-09-21 | 2017-03-30 | Bio-Cancer Treatment International Ltd. | Method to treat cancer using arginine delpetor and ornithine decarboxylase (odc) inhibitor |
| CN105112391B (zh) * | 2015-09-22 | 2018-07-06 | 浙江道尔生物科技有限公司 | 一种人源精氨酸酶突变体及其制备方法和用途 |
| PT3496743T (pt) | 2016-08-08 | 2022-03-30 | Aerase Inc | Composições e métodos para o tratamento do cancro com depleção de arginina e agentes imuno-oncológicos |
| TWI878212B (zh) | 2017-12-05 | 2025-04-01 | 瑞典商伊梅爾迪卡製藥公司 | 用於治療精胺酸酶1缺乏症之方法及組合物 |
| ES3049232T3 (en) | 2018-05-31 | 2025-12-15 | Univ Hong Kong Chinese | Composition and application of arginine-depleting agents for cancer, obesity, metabolic disorders, and related complications and comorbidities |
| MX2021004463A (es) | 2018-10-19 | 2021-08-24 | Aerase Inc | Terapia de disminución de arginina para el tratamiento de la deficiencia de gamt. |
| MX2022002437A (es) | 2019-08-30 | 2022-06-02 | Aeglea Biotherapeutics Inc | Metodos para la produccion de arginasa humana recombinante 1 y sus usos. |
| EP4069280A4 (de) * | 2019-12-02 | 2024-01-03 | The Hong Kong Polytechnic University | Verfahren zur induzierung von intermittierendem fasten und modulation der autophagie |
| CN115804845B (zh) * | 2022-12-02 | 2025-09-30 | 华东理工大学 | 精氨酸剥夺在延缓衰老与联合化疗药物治疗肿瘤中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5780286A (en) * | 1996-03-14 | 1998-07-14 | Smithkline Beecham Corporation | Arginase II |
| US5851985A (en) * | 1996-08-16 | 1998-12-22 | Tepic; Slobodan | Treatment of tumors by arginine deprivation |
| AU5192498A (en) | 1996-12-03 | 1998-06-29 | Kyowa Hakko Kogyo Co. Ltd. | Tissue fibrosis inhibitor |
| WO1999043345A1 (en) | 1998-02-26 | 1999-09-02 | Eisai Co., Ltd. | Amino acid degrading enzymes modulate cell death |
| US6413757B1 (en) * | 2000-02-28 | 2002-07-02 | Millennium Pharmaceuticals, Inc. | 25312, a novel human agmatinase-like homolog |
| CN1324945A (zh) * | 2000-05-19 | 2001-12-05 | 上海博德基因开发有限公司 | 一种新的多肽——精氨酸酶12和编码这种多肽的多核苷酸 |
| CN1324942A (zh) * | 2000-05-19 | 2001-12-05 | 上海博德基因开发有限公司 | 一种新的多肽——人精氨酸酶9和编码这种多肽的多核苷酸 |
| KR100396983B1 (ko) | 2000-07-29 | 2003-09-02 | 이강춘 | 고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체 |
| DE10047204A1 (de) | 2000-09-23 | 2002-04-25 | Henkel Kgaa | Topische Hautbehandlungsmittel mit Arginase |
| CN1345966A (zh) * | 2000-09-26 | 2002-04-24 | 上海博德基因开发有限公司 | 一种新的多肽——人精氨酸酶35.42和编码这种多肽的多核苷酸 |
| CN1345970A (zh) * | 2000-09-29 | 2002-04-24 | 上海博德基因开发有限公司 | 一种新的多肽——含精氨酸酶结构域的蛋白质9.35和编码这种多肽的多核苷酸 |
| KR20040004449A (ko) | 2000-11-28 | 2004-01-13 | 휘닉스 파머컬러직스, 인크. | 변형된 아르기닌 데이미나제 |
| EP1499342A2 (de) | 2002-01-25 | 2005-01-26 | Cancer Treatments International | Therapeutische zusammensetzung zur behandlung von krebs durch arginin-depletion |
-
2002
- 2002-09-06 HK HK02106593A patent/HK1053577A2/xx not_active IP Right Cessation
- 2002-09-09 CN CNA2008102148652A patent/CN101433714A/zh active Pending
- 2002-09-09 CN CN028291794A patent/CN1918298B/zh not_active Expired - Lifetime
- 2002-09-09 AU AU2002325782A patent/AU2002325782A1/en not_active Abandoned
- 2002-09-09 WO PCT/CN2002/000635 patent/WO2004001048A1/en not_active Ceased
-
2003
- 2003-06-20 AT AT03760800T patent/ATE385807T1/de active
- 2003-06-20 MX MXPA04012970A patent/MXPA04012970A/es active IP Right Grant
- 2003-06-20 DE DE60319083T patent/DE60319083T2/de not_active Expired - Lifetime
- 2003-06-20 US US10/518,223 patent/US7951366B2/en not_active Expired - Fee Related
- 2003-06-20 NZ NZ537774A patent/NZ537774A/en not_active IP Right Cessation
- 2003-06-20 AT AT08001266T patent/ATE461707T1/de active
- 2003-06-20 EP EP03760800A patent/EP1517699B1/de not_active Expired - Lifetime
- 2003-06-20 DE DE60331871T patent/DE60331871D1/de not_active Expired - Lifetime
-
2004
- 2004-12-19 IL IL165858A patent/IL165858A/en active IP Right Grant
-
2007
- 2007-02-12 US US11/673,601 patent/US8679810B2/en active Active
- 2007-11-05 US US11/930,109 patent/US20080226617A1/en not_active Abandoned
-
2008
- 2008-07-24 US US12/179,121 patent/US20090123450A1/en not_active Abandoned
-
2010
- 2010-01-15 JP JP2010007090A patent/JP5307042B2/ja not_active Expired - Lifetime
-
2013
- 2013-05-13 JP JP2013101584A patent/JP2013172743A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US7951366B2 (en) | 2011-05-31 |
| CN101433714A (zh) | 2009-05-20 |
| HK1109876A1 (en) | 2008-06-27 |
| DE60331871D1 (de) | 2010-05-06 |
| US20080248018A1 (en) | 2008-10-09 |
| ATE461707T1 (de) | 2010-04-15 |
| DE60319083T2 (de) | 2009-02-05 |
| HK1071687A1 (en) | 2005-07-29 |
| US8679810B2 (en) | 2014-03-25 |
| MXPA04012970A (es) | 2005-08-18 |
| US20090123450A1 (en) | 2009-05-14 |
| IL165858A0 (en) | 2006-01-15 |
| IL165858A (en) | 2010-12-30 |
| JP2010148509A (ja) | 2010-07-08 |
| NZ537774A (en) | 2007-01-26 |
| JP2013172743A (ja) | 2013-09-05 |
| EP1517699B1 (de) | 2008-02-13 |
| AU2002325782A1 (en) | 2004-01-06 |
| CN1918298B (zh) | 2011-06-29 |
| DE60319083D1 (de) | 2008-03-27 |
| WO2004001048A1 (en) | 2003-12-31 |
| US20080226617A1 (en) | 2008-09-18 |
| EP1517699A1 (de) | 2005-03-30 |
| US20050244398A1 (en) | 2005-11-03 |
| HK1053577A2 (en) | 2003-10-10 |
| CN1918298A (zh) | 2007-02-21 |
| JP5307042B2 (ja) | 2013-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE385807T1 (de) | Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug | |
| ATE468137T1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| DE60029799D1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| DE60225556D1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| DE60330485D1 (de) | Zur behandlung von diabetes | |
| ATE507838T1 (de) | Verwendung von dipeptidylpeptidase iv und aminopeptidase-n inhibitoren zur behandlung von ischämie-induzierter neurodegeneration | |
| ATE380548T1 (de) | Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie | |
| DE69827651D1 (de) | Verwendung von tempol zur behandlung von essentiellem hochdruck | |
| ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| ATE350374T1 (de) | Phenylalaninderivate als hemmer der dipeptidyl peptidase zur behandlung oder prävention von diabetes | |
| DE60032795D1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
| EA200601212A1 (ru) | Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение | |
| DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| CY1116164T1 (el) | Προδρομη 4-σουλφαταση ν-ακετυλογαλακτο σαμινης, μεθοδοι θεραπευτικης αγωγης που χρησιμοποιουν το εν λογω ενζυμο και μεθοδοι για παραγωγη και καθαρισμο του εν λογω ενζυμου | |
| ATE390928T1 (de) | Zusammensetzungen zur behandlung von hauterkrankungen | |
| DE60330888D1 (de) | Verwendung von drospirenon zur behandlung von hypertension | |
| DE69625682D1 (de) | Verfahren zur behandlung von entzündungen und zusammensetzungen dafür | |
| ATE487480T1 (de) | Perhexilin zur behandlung von chronischer herzinsuffizienz | |
| EP1143996A4 (de) | Methode zur behandlung von chronischen herzerkrankungen | |
| DE60128084D1 (de) | Verwendung von inaktives cln2 proenzym zur behandlung von lincl | |
| ATE407925T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| DE602004016841D1 (de) | Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1517699 Country of ref document: EP |